Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satyanarayana Alleboina

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Therapy Oncolytics|November 3, 2021
Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitorSatyanarayana Alleboina, Nour Aljouda, Mellessa Miller, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 25, 2020
Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetesSatyanarayana Alleboina, Thomas Wong, Madhu V Singh, et al.
Journal of Clinical & Translational Endocrinology|December 18, 2018
Type 1 diabetes alters ischemia-induced gene expressionRahul Peravali, Lucas Gunnels, Satyanarayana Alleboina, et al.
Vascular Medicine (London, England)|August 28, 2019
Dual specificity phosphatase 5 regulates perfusion recovery in experimental peripheral artery diseaseSatyanarayana Alleboina, Dawit Ayalew, Rahul Peravali, et al.
Molecular Cancer Research : MCR|November 30, 2018
Targeted Therapy for EBV-Associated B-cell NeoplasmsSiddhartha Ganguly, Sudhakiranmayi Kuravi, Satyanarayana Alleboina, et al.
Molecular Oncology|August 9, 2024
Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activityNour A Aljouda, Dewan Shrestha, Chelsea DeVaux, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Therapy Oncolytics|November 3, 2021
Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitorSatyanarayana Alleboina, Nour Aljouda, Mellessa Miller, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 25, 2020
Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetesSatyanarayana Alleboina, Thomas Wong, Madhu V Singh, et al.
Journal of Clinical & Translational Endocrinology|December 18, 2018
Type 1 diabetes alters ischemia-induced gene expressionRahul Peravali, Lucas Gunnels, Satyanarayana Alleboina, et al.
Vascular Medicine (London, England)|August 28, 2019
Dual specificity phosphatase 5 regulates perfusion recovery in experimental peripheral artery diseaseSatyanarayana Alleboina, Dawit Ayalew, Rahul Peravali, et al.
Molecular Cancer Research : MCR|November 30, 2018
Targeted Therapy for EBV-Associated B-cell NeoplasmsSiddhartha Ganguly, Sudhakiranmayi Kuravi, Satyanarayana Alleboina, et al.
Molecular Oncology|August 9, 2024
Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activityNour A Aljouda, Dewan Shrestha, Chelsea DeVaux, et al.
Pageof 1